clinical trials

Home/Tag: clinical trials

Could a Dog Vaccine Help Save Kids With Brain Cancer?

By: Laura Goldman,, April 17, 2017 The statistics are grim: About 60 to 70 percent of children who have glioblastoma, a form of brain cancer, do not survive more than two years. This fast-growing cancer is resistant to traditional treatments like radiation and chemotherapy. For dogs, cancer statistics are also grim. More than 6

Stem cell therapy trial at Sanford first of its kind in U.S. for shoulder injuries

FDA-approved study explores utility of fat-derived stem cells SIOUX FALLS, S.D. – The first FDA-approved clinical trial of its kind in the United States using a person’s own fat-derived adult stem cells to treat shoulder injuries is available at Sanford Health. The trial opened in December and explores if adipose stem cells, which are taken

CIRM-Funded Clinical Trial for ALS Given Go Ahead to Treat Patients

October 24, 2016 Oakland, CA – An ingenious method that uses a patient as their own control has been given clearance to start a clinical trial to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. The California Institute for Regenerative Medicine (CIRM) is funding the trial. ALS is a devastating disease that

October 24th, 2016|Categories: ALS, Clinical Trials|Tags: , , |

Stem Cell Agency Spinal Cord Injury Clinical Trial Passes Safety Hurdles

Posted: August 31, 2016 Oakland, CA – A clinical trial using stem cells to treat people with recent spinal cord injuries has cleared two key safety hurdles, and been given approval to expand the therapy to a larger group of patients with a much higher dose of cells. Asterias Biotherapeutics announced that its Data Monitoring

Laser surgery opens blood-brain barrier to chemotherapy

Technology may improve treatment for deadly brain cancer by Jim Goodwin•February 24, 2016 ROBERT BOSTON PHOTO Washington University neurosurgeon Eric C. Leuthardt, MD, and others have discovered another benefit of laser surgery for patients with glioblastomas, one of the most difficult cancers to treat. In addition to killing the tumors with heat, the technology bypasses

First Trial Of Stem Cell Therapy Treatment For Parkinson’s Disease Will Be In Australia

Dec 15, 2015 09:10 AM EST | By Jackie Pasaol A California-based company received permission to conduct its first ever trial of stem cell therapy treatment for Parkinson's disease in Melbourne. The Therapeutic Goods Administration of Australia cleared the International Stem Cell Corporation's (ISCO) submission to conduct its first trial treatment in twelve patients with

A new treatment for macular degeneration

A patient receives the first human eye cell transplant developed by a UCSB neuroscientist who founded the London Project to Cure Blindness By Julie Cohen Monday, September 28, 2015 - Santa Barbara, CA A clinical trial using stem cell-derived ocular cells for the treatment of wet age-related macular degeneration (AMD) has been initiated in England. This was

Stem Cell Agency Funded Therapy for Blinding Disease Treats First Patients

August 11, 2015 San Francisco, CA – A clinical trial using stem cells to treat people who have lost their vision due to retinitis pigmentosa (RP) has treated its first four patients. CIRM, California’s stem cell agency, is funding the trial, which has FDA consent. “We are delighted to be moving into the clinic after

Study shows promise of precision medicine for most common type of lymphoma

July 20, 2015- NIH- A clinical trial has shown that patients with a specific molecular subtype of diffuse large B-cell lymphoma (DLBCL) are more likely to respond to the drug ibrutinib (Imbruvica) than patients with another molecular subtype of the disease. The study appeared online July 20, 2015, in Nature Medicine. “This is the first

July 20th, 2015|Categories: Cancer, Clinical Trials|Tags: , , |